We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Nomura Holdings
NMR
$28.1B
| $276K | 0.14% |
+32,948
| New | +$246K |
|
327
ICICI Bank
IBN
$109B
| $276K | 0.14% |
+9,246
| New | +$284K |
|
328
Nasdaq
NDAQ
$53.6B
| $275K | 0.14% |
2,836
-1,876
| -40% | -$169K |
|
|
ECG
329
Everus Construction Group
ECG
$5.98B
| $275K | 0.14% |
+3,212
| New | +$287K |
|
330
Cemex
CX
$17.3B
| $275K | 0.14% |
23,901
+11,165
| +88% | +$115K |
|
331
CubeSmart
CUBE
$9.62B
| $274K | 0.14% |
+7,599
| New | +$289K |
|
|
SMA
332
SmartStop Self Storage REIT
SMA
$1.96B
| $274K | 0.14% |
+8,848
| New | +$299K |
|
333
On Holding
ONON
$12.6B
| $273K | 0.14% |
+5,879
| New | +$253K |
|
334
Rithm Capital
RITM
$5.46B
| $273K | 0.14% |
25,025
+356
| +1% | +$3.93K |
|
|
VG
335
Venture Global Inc
VG
$30.2B
| $272K | 0.14% |
39,901
+27,081
| +211% | +$226K |
|
336
Ross Stores
ROST
$80.5B
| $272K | 0.14% |
+1,508
| New | +$252K |
|
337
Climb Global Solutions
CLMB
$524M
| $272K | 0.14% |
+10,568
| New | +$307K |
|
338
Intel
INTC
$435B
| $271K | 0.14% |
+7,355
| New | +$278K |
|
339
Seadrill
SDRL
$2.56B
| $271K | 0.14% |
+7,831
| New | +$244K |
|
340
TD Synnex
SNX
$19.8B
| $270K | 0.14% |
+1,797
| New | +$276K |
|
|
AIV
341
Aimco
AIV
$375M
| $270K | 0.14% |
+45,442
| New | +$272K |
|
|
SGI
342
Somnigroup International
SGI
$15.2B
| $268K | 0.14% |
+3,004
| New | +$262K |
|
343
Valmont Industries
VMI
$9.33B
| $268K | 0.14% |
+666
| New | +$271K |
|
344
J&J Snack Foods
JJSF
$1.49B
| $267K | 0.14% |
+2,958
| New | +$268K |
|
345
Similarweb
SMWB
$630M
| $267K | 0.14% |
+35,684
| New | +$288K |
|
346
Raymond James Financial
RJF
$34B
| $267K | 0.14% |
+1,664
| New | +$269K |
|
347
Alkami Technology
ALKT
$1.94B
| $267K | 0.14% |
+11,581
| New | +$256K |
|
348
Cohen & Steers
CNS
$4.24B
| $267K | 0.14% |
+4,254
| New | +$277K |
|
349
Autodesk
ADSK
$50.1B
| $266K | 0.13% |
+900
| New | +$272K |
|
350
Transcat
TRNS
$804M
| $266K | 0.13% |
+4,688
| New | +$292K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.